Key facts
- Culture Biosciences’s last known valuation is $290.0M (Sep 2021).
- It has raised $107.2M across 1 recorded rounds; the latest was Early Stage VC ($21.6M) in Feb 2020.
- Notable investors include Y Combinator, US National Science Foundation, BoxGroup, DCVC, Craft Ventures — 26 tracked in total.
- Culture Biosciences has filed 1 Form D with the SEC, most recently Mar 2020 ($21.6M sold to 38 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Culture Biosciences
Funding rounds
1 roundsAbout Culture Biosciences
Developer of automated bioreactors and software designed to help companies optimize their manufacturing processes. The company designs, monitors, and analyzes bioreactors for sensitive cell cultures and high cell density fermentation, enabling biotech companies to optimize manufacturing processes and simulate performance at scale.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2016
- Employees
- 80
- Website
- culturebiosciences.com/
- Ownership
- Privately Held (backing)
Culture Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Culture Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Culture Biosciences in its N-PORT filings yet. We sweep new filings monthly.